Structure-Based Exploration of Selectivity for ATM Inhibitors in Huntington’s Disease
出版年份 2021 全文链接
标题
Structure-Based Exploration of Selectivity for ATM Inhibitors in Huntington’s Disease
作者
关键词
-
出版物
JOURNAL OF MEDICINAL CHEMISTRY
Volume 64, Issue 8, Pages 5018-5036
出版商
American Chemical Society (ACS)
发表日期
2021-03-30
DOI
10.1021/acs.jmedchem.1c00114
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Optimization of Potent and Selective Ataxia Telangiectasia-Mutated Inhibitors Suitable for a Proof-of-Concept Study in Huntington’s Disease Models
- (2019) Leticia Toledo-Sherman et al. JOURNAL OF MEDICINAL CHEMISTRY
- Mutant huntingtin impairs PNKP and ATXN3, disrupting DNA repair and transcription
- (2019) Rui Gao et al. eLife
- The Identification of Potent, Selective, and Orally Available Inhibitors of Ataxia Telangiectasia Mutated (ATM) Kinase: The Discovery of AZD0156 (8-{6-[3-(Dimethylamino)propoxy]pyridin-3-yl}-3-methyl-1-(tetrahydro-2H-pyran-4-yl)-1,3-dihydro-2H-imidazo[4,5-c]quinolin-2-one)
- (2018) Kurt G. Pike et al. JOURNAL OF MEDICINAL CHEMISTRY
- Orally bioavailable and blood-brain-barrier penetrating ATM inhibitor (AZ32) radiosensitizes intracranial gliomas in mice.
- (2018) Jeremy Karlin et al. MOLECULAR CANCER THERAPEUTICS
- Discovery of a Series of 3-Cinnoline Carboxamides as Orally Bioavailable, Highly Potent, and Selective ATM Inhibitors
- (2018) Bernard Barlaam et al. ACS Medicinal Chemistry Letters
- The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor models
- (2018) Stephen T. Durant et al. Science Advances
- Discovery of Novel 3-Quinoline Carboxamides as Potent, Selective, and Orally Bioavailable Inhibitors of Ataxia Telangiectasia Mutated (ATM) Kinase
- (2016) Sébastien L. Degorce et al. JOURNAL OF MEDICINAL CHEMISTRY
- CNS Drug Design: Balancing Physicochemical Properties for Optimal Brain Exposure
- (2015) Zoran Rankovic JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of (2S)-8-[(3R)-3-Methylmorpholin-4-yl]-1-(3-methyl-2-oxobutyl)-2-(trifluoromethyl)-3,4-dihydro-2H-pyrimido[1,2-a]pyrimidin-6-one: A Novel Potent and Selective Inhibitor of Vps34 for the Treatment of Solid Tumors
- (2014) Benoit Pasquier et al. JOURNAL OF MEDICINAL CHEMISTRY
- Targeting ATM ameliorates mutant Huntingtin toxicity in cell and animal models of Huntington's disease
- (2014) X.-H. Lu et al. Science Translational Medicine
- The ATM protein kinase: regulating the cellular response to genotoxic stress and more
- (2013) Yosef Shiloh et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Discovery of 4-morpholino-pyrimidin-6-one and 4-morpholino-pyrimidin-2-one-containing Phosphoinositide 3-kinase (PI3K) p110β isoform inhibitors through structure-based fragment optimisation
- (2012) Fabrizio Giordanetto et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Identification of Small Molecule Inhibitors of Phosphatidylinositol 3-Kinase and Autophagy
- (2011) Thomas Farkas et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Defining Desirable Central Nervous System Drug Space through the Alignment of Molecular Properties, in Vitro ADME, and Safety Attributes
- (2010) Travis T. Wager et al. ACS Chemical Neuroscience
- Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success
- (2009) Frank Lovering et al. JOURNAL OF MEDICINAL CHEMISTRY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started